Company / Book Value per Share
Jazz Pharmaceuticals Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$71.227
FY2025
5-year range
$55.384 / $71.227
FY2021-FY2025
Trend
+8.3%
vs FY2024
Sector context
#8 of 209
Health Care
What the data says
Among 209 Health Care companies, Jazz Pharmaceuticals is in the top 4% for book value per share. Improved from $59.117 to $71.227 over the past 2 years.
Based on SEC 10-K filings.
$71.227 in FY2025 with a 5-year CAGR of +7.7%. Top quartile in the Health Care sector.
Improved from $59.117 to $71.227 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- +6.3%
- 5-Year CAGR
- +7.7%
- 10-Year CAGR
- -
Sector benchmark
Top 4% in Health CareTop 4% of 209This company $71.227 Sector average $215.686
▼
-67.0% below sector average
Key checks
Key Insights
- 5-year CAGR of +7.7%, indicating consistent growth.
- In FY2025, book value per share increased 8.3% year-over-year.
- Ranks #8 out of 209 companies in the Health Care sector.
- Lowest book value per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.66 (distress zone, below 1.8 threshold)
- Negative profit margin: -8.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $71.227 | +8.3% |
| FY2024 | $65.758 | +11.2% |
| FY2023 | $59.117 | -0.4% |
| FY2022 | $59.38 | +7.2% |
| FY2021 | $55.384 | +12.8% |
| FY2020 | $49.117 | +4.5% |
| FY2019 | $47.017 | +2.1% |
| FY2018 | $46.064 | +1.6% |
| FY2017 | $45.354 | +102.8% |
| FY2016 | $22.367 | -15.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026